Form D · Venture Capital Fund
Harbright 2026 VQ Biomedical Series, a series of Harbright LLC
Cary, NC · CIK 0002138549
Offering snapshot reported Jul 8, 2026 · SEC filing
- Reported sold
- $597K Offering amount: $1M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jun 29, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 8, 2026 | Initial | $597,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-590029
Source: Form D, filed Jul 8, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Michael Harlow | Director, Promoter |
| John Powell Leachman | Director, Promoter |
| Robert Earl Ross | Director, Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
107 Kilmayne Drive Suite B
Cary, NC, 27511
Cary, NC, 27511